ACADIA Pharmaceuticals acadia-pharm.com


Public list: BIO 2016 (619) Pharma Startups (6570) Eye Health (703) Neuroscience Startups (947)

ACADIA Pharmaceuticals, formerly Recptor Technologies, is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company has five drug programs in clinical and preclinical development. ACADIA's three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease currently in Phase II clinical trials, and ACP-104 and ACP-103, both for the treatment of schizop...Show all

ACADIA Pharmaceuticals, formerly Recptor Technologies, is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company has five drug...Show all

Company (IPO / Went public)

Phone: 858-558-2871

Fax:

3911 Sorrento Valley Boulevard

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ACADIA Pharmaceuticals $47.7M Apr 6, 2005
Alexza Pharmaceuticals $163.4M May 10, 2016
Agios Pharmaceuticals $376.3M Jul 24, 2013
See all 5 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ACADIA Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 5 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of treatment using selective 5-ht2a inverse agonists Mar 21, 2011 Sep 19, 2017 Patent
Methods for the treatment of parkinson's disease psychosis using pimavanserin Aug 24, 2016 Sep 12, 2017 Patent
Muscarinic agonists Mar 14, 2014 Jun 06, 2017 Patent
Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases Nov 06, 2015 Feb 14, 2017 Patent
Tetrahydroquinoline analogues as muscarinic agonists Feb 05, 2014 Dec 20, 2016 Patent
See all 46 patents